アルコール性肝障害（アルコール関連肝疾患）診療ガイド　2022

出版社： 文光堂
著者：
発行日： 2022-10-16
分野： 臨床医学：内科  >  肝/胆/膵
ISBN： 9784830621130
電子書籍版： 2022-10-16 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

1,650 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,650 円(税込)

購入する

商品紹介

日本肝臓学会編集によるアルコールによる臓器障害を取り上げた初の診療ガイドブック．日本における1日平均アルコール摂取量60g以上の多量飲酒者は約860万人と推測されており，アルコール性肝障害（アルコール関連肝疾患）による死亡者数は増加傾向にある．本書ではアルコール性肝障害の疫学，病態生理，診断に関する最新のエビデンス，生活指導から薬物療法に至るマネジメント・治療の実際までを網羅して取り上げ，エキスパートオピニオンとして実践的に解説した．診療で必要な知識やスキルの具体的なポイントをまとめた，全臨床医必携の一冊．

目次

  • 第1章　疾患概念
    　1. アルコールによる健康被害と肝障害
    　2. アルコール依存症とアルコール使用障害─その概念と診断
    　［1］アルコール依存症の概念
    　［2］アルコール依存症の診断
    　［3］アルコール依存症とアルコール使用障害の概念の相違と問題点
    　3. わが国におけるアルコール性肝障害（ALD）の診断基準─その変遷と現状
    　4. ALDの病型分類と進展様式
    　5. 重症アルコール性肝炎の問題
    　6. ALDの概念の国際動向
    　7. ALDと非アルコール性脂肪性肝疾患（NAFLD）
    　8. 飲酒量低減治療とハームリダクション

    第2章　疫学的側面
    　1. わが国のアルコール消費の実態
    　2. わが国のアルコール使用障害の実態
    　3. アルコール性肝障害（ALD）の国際的動向とわが国における実態
    　4. ALDの予後

    第3章　病態生理
    　1. 概論
    　2. 肝細胞障害機序
    　［1］肝細胞におけるエタノール代謝とミトコンドリア障害
    　［2］酸化ストレスや小胞体（ER）ストレスを介した肝細胞死
    　［3］腸内細菌叢の肝細胞障害への関与
    　［4］肝微小循環障害の肝細胞障害への関与
    　3. 肝細胞内脂肪滴貯留機序
    　4. 肝線維化進展機序
    　5. 肝発癌機序
    　6. 炎症による他臓器を介した肝臓との連関
    　7. アルコール性肝障害（ALD）と性差

    第4章　診断
    　1. 病理診断（肝生検）
    　［1］肝生検
    　［2］病理所見
    　2. 臨床診断（バイオマーカー・非侵襲的診断の活用）
    　［1］飲酒マーカー
    　［2］肝線維化マーカー
    　［3］重症度スコア

    第5章　マネジメント・治療
    　1. 脂肪肝・脂肪肝炎への対応
    　［1］代謝異常の頻度
    　［2］肥満
    　［3］糖尿病
    　2. 重症アルコール性肝炎，acute-on-chronic liver failure（ACLF）の治療
    　［1］治療の概要
    　［2］内科的治療の各論
    　［3］全国集計からみた治療の実態
    　3. アルコール性肝硬変のマネジメント
    　［1］栄養サポート
    　［2］合併症対策
    　4. アルコール性肝癌の対策
    　5. 非代償性肝硬変，アルコール性肝炎/ACLF，肝細胞癌合併例に対する肝移植
    　［1］アルコール性の非代償性肝硬変
    　［2］重症アルコール性肝炎/ACLF
    　［3］肝細胞癌合併例
    　6. 臓器障害に対する断酒と飲酒量低減治療
    　［1］アルコール関連臓器障害に対する断酒
    　［2］アルコール関連臓器障害に対する飲酒量低減治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.10 掲載の参考文献
1) World Health Organization : The ICD-10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines, World Health Organization, 1992
 
2) World Health Organization : International Classification of Diseases 11th Revision, The global standard for diagnostic health information. https://icd.who.int/en (閲覧2022年8月)
 
3) American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition DSM-5(R), American Psychiatric Association Publishing, 2013
 
4) European Association for the Study of the Liver : EASL Clinical Practice Guidelines : Management of alcohol-related liver disease. J Hepatol 69 : 154-181, 2018
 
5) Crabb DW et al : Diagnosis and Treatment of Alcohol-Associated Liver Diseases : 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 71 : 306-333, 2020
 
6) アルコール医学生物学研究会 (編) : アルコール性肝障害診断基準 2011年版, 響文社, 2012
 
7) アルコール医学生物学研究会 アルコール性肝障害診断基準見直しのためのワーキンググループ : JASBRAアルコール性肝障害診断基準 2011年版 (2021年小改訂). http://plaza.umin.ac.jp/jasbra/sub-kijyun.html (閲覧2022年8月)
 
8) European Association for the Study of the Liver (EASL), et al : EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64 : 1388-1402, 2016
 
9) Chalasani N, et al : The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67 : 328-357, 2018
 
10) 日本消化器病学会・日本肝臓学会 (編) : NAFLD/NASH診療ガイドライン 2020, 改訂第2版, 南江堂, 2020
 
11) Tokushige K, et al : Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol 56 : 951-963, 2021
PubMed
12) Eslam M et al : A new definition for metabolic dysfunction-associated fatty liver disease : An international expert consensus statement. J Hepatol 73 : 202-209, 2020
PubMed
13) 新アルコール・薬物使用障害の診断治療ガイドライン作成委員会 (監) : 新アルコール・薬物使用障害の診断治療ガイドライン, 新興医学出版社, 2018
 
P.16 掲載の参考文献
1) 国税庁課税部酒税課 : 酒のしおり (令和4年3月). https://www.nta.go.jp/taxes/sake/shiori-gaikyo/shiori/2022/index.htm (閲覧2022年8月)
 
2) OECD Data : Alcohol consumption, 2020, doi : 10.1787/e6895909-en. https://data.oecd.org/healthrisk/alcohol-consumption.htm (閲覧2022年8月)
 
3) 湯本洋介ほか : アルコール関連問題におけるわが国の状況と世界の動向. 医のあゆみ 274 : 14-19, 2020
Medical*Online
4) 岩原千絵ほか : 女性とアルコール関連問題. 医のあゆみ 274 : 104-109, 2020
Medical*Online
5) 厚生労働省 : 令和元年 国民健康・栄養調査報告. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html (閲覧2022年8月)
 
6) 日本医療研究開発機構 (AMED) : 「アルコール依存症の実態把握, 地域連携による早期介入・回復プログラムの開発に関する研究」 (研究代表者 樋口進) 2016-2018, 2019
 
7) WHO : Global Status Report on Alcohol and Health 2018. https://www.who.int/publications/i/item/9789241565639 (閲覧2022年8月)
 
8) Crabb DW et al : Diagnosis and treatment of alcohol-associated liver diseases : 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 71 : 306-333, 2020
 
9) アルコール健康障害対策基本法推進ネットワーク : アルコール関連問題. http://alhonet.jp/problem.html (閲覧2022年8月)
 
10) 厚生労働省 : 患者調査. https://www.mhlw.go.jp/toukei/list/10-20.html (閲覧2022年8月)
 
11) 厚生労働省 : 第2 期アルコール健康障害対策推進基本計画. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000176279.html (閲覧2022年8月)
 
12) Enomoto H et al : Transition in the etiology of liver cirrhosis in Japan : a nationwide survey. J Gastroenterol 55 : 353-362, 2020
PubMed
13) Enomoto H et al : The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. J Gastroenterol 56 : 158-167, 2021
 
14) 厚生労働省 : 人口動態調査. https://www.mhlw.go.jp/toukei/list/81-1a.html (閲覧2022年8月)
 
15) Yokoyama A et al : The impact of diabetes mellitus on the prognosis of alcoholics. Alcohol Alcohol 29 : 181-186, 1994
PubMed
P.23 掲載の参考文献
1) Lieber CS : Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta 257 : 59-84, 1997
PubMed
2) Karahanian E et al : Ethanol as a prodrug : brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res 35 : 606-612, 2011
PubMed
3) Yoshida A et al : Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. Alcohol 2 : 103-106, 1985
PubMed
4) Matejcic M et al : Alcohol metabolism and oesophageal cancer : a systematic review of the evidence. Carcinogenesis 38 : 859-872, 2017
PubMed
5) Cederbaum AI : Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 28 : 802-811, 2010
PubMed
6) Hirano T et al : Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 16 : 1423-1427, 1992
PubMed
7) Han D et al : Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice : biogenesis, remodeling, and functional alterations. J Biol Chem 287 : 42165-42179, 2012
PubMed
8) Lange LG et al : Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest 72 : 724-731, 1983
PubMed
9) Ji C : New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. Int J Hepatol 2014 : 513787, 2014
PubMed
10) Ji C et al : Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29 : 1496-1503, 2005
PubMed
11) Gao B et al : Inflammatory pathways in alcoholic steatohepatitis. J Hepatol 70 : 249-259, 2019
PubMed
12) Mandrekar P et al : Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50 : 1258-1266, 2009
PubMed
13) Roychowdhury S et al : Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57 : 1773-1783, 2013
PubMed
14) Khanova E et al : Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67 : 1737-1753, 2018
PubMed
15) Schwabe RF et al : Apoptosis and necroptosis in the liver : a matter of life and death. Nat Rev Gastroenterol Hepatol 15 : 738-752, 2018
PubMed
16) Knorr J et al : The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 40 : 298-306, 2020
PubMed
17) de Carvalho Ribeiro M et al : Role of the inflammasome in liver disease. Annu Rev Pathol 17 : 345-365, 2022
PubMed
18) Schnabl B et al : Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146 : 1513-1524, 2014
PubMed
19) Adachi Y et al : Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20 : 453-460, 1994
PubMed
20) Chen P et al : Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 61 : 883-894, 2015
PubMed
21) Duan Y et al : Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575 : 505-511, 2019
PubMed
22) Yang Y et al : Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease. J Hepatol 75 : 377-386, 2021
PubMed
23) Oshita M et al : Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest 91 : 1337-1342, 1993
 
24) Medina J et al : Angiogenesis in chronic inflammatory liver disease. Hepatology 39 : 1185-1195, 2004
PubMed
25) Baraona E et al : Effects of ethanol on lipid metabolism. J Lipid Res 20 : 289-315, 1979
PubMed
26) You M et al : The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127 : 1798-1808, 2004
PubMed
27) You M et al : Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277 : 29342-29347, 2002
PubMed
28) Esfandiari F et al : Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology 51 : 932-941, 2010
PubMed
29) Gopal T et al : A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. Alcohol Clin Exp Res 45 : 1927-1939, 2021
 
30) Lieber CS et al : Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 45 : 51-62, 1966
PubMed
31) Xu J et al : Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice. JCI Insight 5 : e131277, 2020
PubMed
32) Tilg H et al : Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology 64 : 955-965, 2016
PubMed
33) Kisseleva T et al : Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18 : 151-166, 2021
PubMed
34) Casini A et al : Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13 : 758-765, 1991
PubMed
35) Nieto N et al : Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J Biol Chem 277 : 9853-9864, 2002
PubMed
36) An L et al : Cytokines in alcoholic liver disease. Arch Toxicol 86 : 1337-1348, 2012
PubMed
37) Hikita H et al : Activation of the mitochondrial apoptotic pathway produces reactive oxygen species and oxidative damage in hepatocytes that contribute to liver tumorigenesis. Cancer Prev Res (Phila) 8 : 693-701, 2015
PubMed
38) Nozaki Y et al : Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Sci Rep 11 : 3363, 2021
PubMed
39) Wilson DM 3rd et al : Acute ethanol exposure suppresses the repair of O6-methylguanine DNA lesions in castrated adult male rats. Alcohol Clin Exp Res 18 : 1267-1271, 1994
PubMed
40) Garro AJ et al : Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption. Cancer Res 41 : 120-124, 1981
PubMed
41) Chen CL et al : Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. J Clin Invest 123 : 2832-2849, 2013
 
42) Mercer KE et al : Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway. Cancer Prev Res (Phila) 7 : 675-685, 2014
 
43) Norton R et al : Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed) 295 : 80-82, 1987
PubMed
44) Marshall AW et al : Ethanol elimination in males and females : relationship to menstrual cycle and body composition. Hepatology 3 : 701-706, 1983
PubMed
45) Frezza M et al : High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322 : 95-99, 1990
PubMed
46) Chao TC et al : Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol 160 : 43-49, 1995
PubMed
47) Yin M et al : Estrogen is involved in early alcohol-induced liver injury in a rat enteral feeding model. Hepatology 31 : 117-123, 2000
 
P.33 掲載の参考文献
1) European Association for the Study of the Liver : EASL Clinical Practice Guidelines : Management of alcohol-related liver disease. J Hepatol 69 : 154-181, 2018
 
2) Singal AK et al : ACG Clinical Guideline : Alcoholic Liver Disease. Am J Gastroenterol 113 : 175-194, 2018
PubMed
3) Crabb DW et al : Diagnosis and Treatment of Alcohol-Associated Liver Diseases : 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 71 : 306-333, 2020
 
4) アルコール医学生物学研究会 アルコール性肝障害診断基準見直しのためのワーキンググループ : JASBRAアルコール性肝障害診断基準 2011年版 (2021年小改訂). http://plaza.umin.ac.jp/jasbra/sub-kijyun.html (閲覧2022年8月)
 
5) Levin DM et al : Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66 : 429-434, 1979
PubMed
6) O'Shea RS et al : Alcoholic liver disease. Am J Gastroenterol 105 : 14-32, 2010
PubMed
7) Lucey MR et al : Alcoholic hepatitis. N Engl J Med 360 : 2758-2769, 2009
PubMed
8) Crabb DW et al : Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis : Recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 150 : 785-790, 2016
PubMed
9) Arab JP et al : Alcohol-related liver disease : Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 18 : 518-535, 2019
 
10) Esposito AA et al : Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease. Radiol Med 113 : 1008-1017, 2008
PubMed
11) Worner TM et al : Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254 : 627-630, 1985
PubMed
12) Tanaka T et al : Contribution of hepatitis C virus to the progression of alcoholic liver disease. Alcohol Clin Exp Res 24 : 112S-116S, 2000
 
13) Nissenbaum M et al : Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. Dig Dis Sci 35 : 891-896, 1990
 
14) Mathurin P et al : Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110 : 1847-1853, 1996
PubMed
15) Duvoux C et al : Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis. Hepatology 40 : 1370-1378, 2004
PubMed
16) Altamirano J et al : A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 146 : 1231-1239.e6, 2014
 
17) Hietala J et al : Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 41 : 528-533, 2006
PubMed
18) Suzuki T et al : Accuracy of carbohydrate-deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism. Hepatol Res 52 : 120-127, 2022
PubMed
19) Staufer K et al : Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology 54 : 1640-1649, 2011
PubMed
20) Naveau S et al : Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 3 : 167-174, 2005
PubMed
21) Thiele M et al : Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology 154 : 1369-1379, 2018
PubMed
22) Naveau S et al : Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 49 : 97-105, 2009
PubMed
23) Pavlov CS et al : Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev 1 : CD010542, 2015
PubMed
24) Thiele M et al : Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis. Gastroenterology 150 : 123-133, 2016
PubMed
25) Nguyen-Khac E et al : Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan : prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28 : 1188-1198, 2008
PubMed
26) Younossi ZM, et al : Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology 68 : 349-360, 2018
PubMed
27) Lombardi R et al : Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 21 : 11044-11052, 2015
PubMed
28) Urashima S et al : Histochemical study of hyaluronate in alcoholic liver disease. Alcohol Clin Exp Res 23 : 56S-60S, 1999
PubMed
29) Louvet A et al : Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology 149 : 398-406.e8, 2015
 
P.48 掲載の参考文献
1) Crabb DW et al : Diagnosis and Treatment of Alcohol-Associated Liver Diseases : 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 71 : 306-333, 2020
 
2) Chiang DJ et al : The impact of obesity and metabolic syndrome on alcoholic liver disease. Clin Liver Dis 18 : 157-163, 2014
PubMed
3) Taniai M et al : Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease : Obesity does not influence the severity of alcoholic liver disease. Hepatol Res 42 : 359-367, 2012
PubMed
4) Vancampfort D et al : The prevalence of metabolic syndrome in alcohol use disorders : A systematic review and meta-analysis. Alcohol Alcohol 51 : 515-521, 2016
PubMed
5) Eslam M et al : A new definition for metabolic dysfunction-associated fatty liver disease : An international expert consensus statement. J Hepatol 73 : 202-209, 2020
PubMed
6) Eslam M et al : The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 14 : 889-919, 2020
 
7) Yamamura S et al : MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40 : 3018-3030, 2020
PubMed
8) Tsutsumi T et al : MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD : Generalized estimating equation approach. Hepatol Res 51 : 1115-1128, 2021
PubMed
9) Naveau S et al : Excess weight risk factor for alcoholic liver disease. Hepatology 25 : 108-111, 1997
PubMed
10) Kasztelan-Szczerbinska B et al : Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflamm 2013 : 148526, 2013
PubMed
11) Stepanova M et al : Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease : a population-based study. Gut 59 : 1410-1415, 2010
PubMed
12) Hart CL et al : Effect of body mass index and alcohol consumption on liver disease : analysis of data from two prospective cohort studies. BMJ 340 : c1240, 2010
PubMed
13) Loomba R et al : Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma : a prospective cohort study. Am J Epidemiol 177 : 333-342, 2013
PubMed
14) Torisu Y et al : Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis : A preliminary report. Hepatol Res 37 : 517-523, 2007
PubMed
15) Yokoyama A et al : The impact of diabetes mellitus on the prognosis of alcoholics. Alcohol Alcohol 29 : 181-186, 1994
PubMed
16) Bank S et al : Chronic pancreatitis : clinical features and medical management. Am J Gastroenterol 81 : 153-167, 1986
PubMed
17) Iversen J et al : Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology 87 : 1138-1143, 1984
PubMed
18) Hernaez R et al : Acute-on-chronic liver failure : an update. Gut 66 : 541-553, 2017
PubMed
19) Gines P et al : Management of critically-ill cirrhotic patients. J Hepatol 56 : S13-S24, 2012
PubMed
20) Nadim MK et al : Management of the critically ill patient with cirrhosis : A multidisciplinary perspective. J Hepatol 64 : 717-735, 2016
PubMed
21) Kribben A et al : Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142 : 782-789.e3, 2012
 
22) Heemann U et al : Albumin dialysis in cirrhosis with superimposed acute liver injury : a prospective, controlled study. Hepatology 36 : 949-958, 2002
PubMed
23) Hassanein TI et al : Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46 : 1853-1862, 2007
PubMed
24) Banares R et al : Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure : the RELIEF trial. Hepatology 57 : 1153-1162, 2013
PubMed
25) Tandon R et al : Artificial liver support systems. J Gastroenterol Hepatol 36 : 1164-1179, 2021
PubMed
26) Finkenstedt A et al : Acute-on-chronic liver failure : excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl 19 : 879-886, 2013
 
27) Mathurin P et al : Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH) : individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 36 : 480-487, 2002
 
28) 堀江義則ほか : アルコール性肝炎重症度スコアの有用性の検証と治療介入による予後への影響についての検討. 肝臓 55 : 22-32, 2014
 
29) Thursz MR et al : Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 372 : 1619-1628, 2015
 
30) 井上和明ほか : On-line HDFを急性肝不全の患者に施行する際の診療ガイド. 肝臓 61 : 47-60, 2020
 
31) Tsuji Y et al : Severe alcoholic hepatitis successfully treated by leukocytapheresis : a case report. Alcohol Clin Exp Res 27 (8 Suppl) : 26S-31S, 2003
 
32) Okubo K et al : Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis. Intern Med 45 : 155-158, 2006
PubMed
33) Kumashiro R et al : Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report. Hepatol Res 36 : 229-236, 2006
PubMed
34) Morris JM et al : Granulocytapheresis in the treatment of severe alcoholic hepatitis : a case series. Eur J Gastroenterol Hepatol 22 : 457-460, 2010
PubMed
35) Kamimura K et al : Granulocytapheresis for the treatment of severe alcoholic hepatitis : a case series and literature review. Dig Dis Sci 59 : 482-488, 2014
PubMed
36) Horie Y : Granulocytapheresis and plasma exchange for severe alcoholic hepatitis. J Gastroenterol Hepatol 27 (Suppl 2) : 99-103, 2012
 
37) Watanabe K et al : Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis. J Gastroenterol 52 : 830-837, 2017
PubMed
38) Mochida S et al : Proposed diagnostic criteria for acute-on-chronic liver failure in Japan. Hepatol Res 48 : 219-224, 2018
PubMed
39) 持田智ほか : 我が国におけるAcute-On-Chronic Liver Failure (ACLF) の診断基準 (案). 肝臓 59 : 155-161, 2018
 
40) 持田智ほか : 我が国におけるAcute on Chronic Liver Failure (ACLF) の全国調査 (2017年). 厚生労働科学研究費補助金 (難治性疾患政策研究事業) 「難治性の肝・胆道疾患に関する調査研究」平成30年度総括・分担研究報告書, 2019. https://mhlw-grants.niph.go.jp/project/27174 (閲覧2022年8月)
 
41) 持田智ほか : 我が国におけるAcute on Chronic Liver Failure (ACLF) の全国調査 (2018年). 厚生労働科学研究費補助金 (難治性疾患政策研究事業) 「難治性の肝・胆道疾患に関する調査研究」, 令和元年度総括・分担研究報告書, 2020. https://mhlw-grants.niph.go.jp/project/27806 (閲覧2022年8月)
 
42) 持田智ほか : 我が国におけるAcute on Chronic Liver Failure (ACLF) の全国調査 (2019年). 厚生労働科学研究費補助金 (難治性疾患政策研究事業) 「難治性の肝・胆道疾患に関する調査研究」令和2年度総括・分担研究報告書, 2021. https://mhlw-grants.niph.go.jp/project/147343 (閲覧2022年8月)
 
43) Nakayama N et al : Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria. J Gastroenterol 56 : 1092-1106, 2021
PubMed
44) Bischoff SC et al : ESPEN practical guideline : Clinical nutrition in liver disease. Clin Nutr 39 : 3533-3562, 2020
PubMed
45) Dasarathy S : Nutrition and alcoholic liver disease : Effects of alcoholism on nutrition, effects of nutrition on alcoholic liver disease, and nutritional therapies for alcoholic liver disease. Clin Liver Dis 20 : 535-550, 2016
PubMed
46) Dasarathy J et al : Sarcopenia in alcoholic liver disease : Clinical and molecular advances. Alcohol Clin Exp Res 41 : 1419-1431, 2017
PubMed
47) Moreno C et al : Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology 150 : 903-910.e8, 2016
 
48) Fialla AD et al : Nutritional therapy in cirrhosis or alcoholic hepatitis : a systematic review and meta-analysis. Liver Int 35 : 2072-2078, 2015
PubMed
49) Antar R et al : A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol 26 : 463-467, 2012
PubMed
50) Nielsen K et al : Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 69 : 665-679, 1993
PubMed
51) Nielsen K et al : Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 74 : 557-567, 1995
PubMed
52) Plauth M et al : ESPEN Guidelines on Enteral Nutrition : Liver disease. Clin Nutr 25 : 285-294, 2006
PubMed
53) 日本消化器病学会・日本肝臓学会 (編) : 肝硬変診療ガイドライン 2020, 改訂第3版, 南江堂, 2020. https://www.jsge.or.jp/guideline/guideline/kankohen.html (閲覧2022年8月)
 
54) Tsien CD et al : Late evening snack : exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 27 : 430-441, 2012
PubMed
55) Phillips M et al : Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomised clinical trial. J Hepatol 44 : 784-790, 2006
PubMed
56) McClain C et al : Role of zinc in the development/progression of alcoholic liver disease. Curr Treat Options Gastroenterol 15 : 285-295, 2017
PubMed
57) Wiegand J et al : Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis. Aliment Pharmacol Ther 35 : 1443-1450, 2012
PubMed
58) Altamirano J et al : Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 10 : 65-71.e3, 2012
 
59) Serste T et al : The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int 35 : 1974-1982, 2015
PubMed
60) Jalan R et al : Bacterial infections in cirrhosis : a position statement based on the EASL Special Conference 2013. J Hepatol 60 : 1310-1324, 2014
PubMed
61) Gustot T et al : Sepsis in alcohol-related liver disease. J Hepatol 67 : 1031-1050, 2017
PubMed
62) Hmoud BS et al : Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis : a meta-analysis of randomized trials. Liver Int 36 : 721-728, 2016
PubMed
63) Vergis N et al : In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA. Gastroenterology 152 : 1068-1077.e4, 2017
 
64) Mancebo A et al : Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin Gastroenterol Hepatol 11 : 95-101, 2013
PubMed
65) Heckley GA et al : How the risk of liver cancer changes after alcohol cessation : a review and meta-analysis of the current literature. BMC Cancer 11 : 446, 2011
PubMed
66) LoConte NK et al : Alcohol and Cancer : A Statement of the American Society of Clinical Oncology. J Clin Oncol 36 : 83-93, 2018
 
67) Sahlman P et al : Cancer incidence among alcoholic liver disease patients in Finland : A retrospective registry study during years 1996-2013. Int J Cancer 138 : 2616-2621, 2016
PubMed
68) Gao B et al : Alcoholic liver disease : pathogenesis and new therapeutic targets. Gastroenterology 141 : 1572-1585, 2011
PubMed
69) Terrault NA et al : Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance. Hepatology 67 : 1560-1599, 2018
PubMed
70) Ghany MG et al : Hepatitis C Guidance 2019 Update : American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology 71 : 686-721, 2020
 
71) Ajmera VH et al : Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology 65 : 2090-2099, 2017
PubMed
72) Jarvis H et al : Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. BMJ Open 12 : e049767, 2022
PubMed
73) Stickel F et al : The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 66 : 195-211, 2017
PubMed
74) Stickel F et al : Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Am J Gastroenterol 113 : 1475-1483, 2018
 
75) Heimbach JK et al : AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67 : 358-380, 2018
PubMed
76) European Association for the Study of the Liver : EASL Clinical Practice Guidelines : Management of hepatocellular carcinoma. J Hepatol 69 : 182-236, 2018
 
77) Kokudo N et al : Clinical practice guidelines for hepatocellular carcinoma : The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res 49 : 1109-1113, 2019
PubMed
78) 日本肝移植学会 : 特集「日本移植学会 2019年症例登録 統計報告」肝移植症例登録報告. 移植 55 : 245-260, 2020
 
79) Adam R et al : 2018 Annual Report of the European Liver Transplant Registry (ELTR) -50-year evolution of liver transplantation. Transpl Int 31 : 1293-1317, 2018
PubMed
80) Singal AK et al : Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 95 : 755-760, 2013
PubMed
81) 日本肝臓学会肝移植委員会 : 脳死肝移植希望者 (レシピエント) 適応基準の改訂 (2019年6月7日). https://www.jsh.or.jp/lib/files/medical/news/2019/0701_01_01.pdf (閲覧2022年8月)
 
82) Egawa H et al : Significance of pretransplant abstinence on harmful alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan. Hepatol Res 44 : E428-436, 2014
PubMed
83) Beresford TP et al : Towards standardizing the alcoholism evaluation of potential liver transplant recipients. Alcohol Alcohol 53 : 135-144, 2018
PubMed
84) Everhart JE et al : Liver transplantation for alcoholic liver disease : a survey of transplantation programs in the United States. Liver Transpl Surg 3 : 220-226, 1997
PubMed
85) Beresford TP : Psychiatric assessment of alcoholic candidates for liver transplantation. In Lucey MR et al eds, Liver Transplantation and the Alcoholic Patient : Medical, Surgical and Psychosocial Issues, Cambridge University Press, 29-49, 1994
 
86) Lucey MR et al : Minimal criteria for placement of adults on the liver transplant waiting list : a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3 : 628-637, 1997
 
87) Leong J et al : Evaluation and selection of the patient with alcoholic liver disease for liver transplant. Clin Liver Dis 16 : 851-863, 2012
PubMed
88) Mathurin P et al : Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 365 : 1790-1800, 2011
PubMed
89) Mathurin P et al : Alcohol, liver disease, and transplantation : shifting attitudes and new understanding leads to changes in practice. Curr Opin Organ Transplant 23 : 175-179, 2018
PubMed
90) Kollmann D et al : Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment - a retrospective study. Transpl Int 29 : 559-567, 2016
PubMed
91) Martin P et al : Evaluation for liver transplantation in adults : 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 59 : 1144-1165, 2014
 
92) Rodrigue JR et al : The Alcohol Relapse Risk Assessment : a scoring system to predict the risk of relapse to any alcohol use after liver transplant. Prog Transplant 23 : 310-318, 2013
PubMed
93) Maldonado JR et al : The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) : a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics 53 : 123-132, 2012
 
94) Beresford TP et al : A rational approach to liver transplantation for the alcoholic patient. Psychosomatics 31 : 241-254, 1990
PubMed
95) Yates WR et al : Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol 54 : 645-651, 1993
 
96) De Gottardi A et al : A simple score for predicting alcohol relapse after liver transplantation : results from 387 patients over 15 years. Arch Intern Med 167 : 1183-1188, 2007
PubMed
97) Elfeki MA et al : Early liver transplantation : an evolving therapeutic option for alcohol-associated liver disease. J Clin Exp Hepatol 12 : 3-5, 2022
PubMed
98) Louvet A et al : The Lille model : a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 45 : 1348-1354, 2007
 
99) 中山伸朗 : アルコールと肝不全・ACLF-わが国のアルコール性肝硬変に生じたACLFの実態-. 日消誌 119 : 30-38, 2022
Medical*Online
100) Lee BP et al : Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology 155 : 422-430.e1, 2018
 
101) Lee BP et al : Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology 157 : 472-480.e5, 2019
 
102) Choi G et al : Barriers for liver transplant in patients with alcohol-related hepatitis. J Clin Exp Hepatol 12 : 13-19, 2022
PubMed
103) 日本肝臓学会 : 肝細胞癌の脳死肝移植に関する適応基準と選択基準の改訂について (2019年7月1日). https://www.jsh.or.jp/medical/news/2019/0701_01.html (閲覧2022年8月)
 
104) 日本肝臓学会 (編) : CQ26 肝細胞癌に対する肝移植の適応基準は何か? 肝癌診療ガイドライン 2021年版, 金原出版, 150-153, 2021
 
105) 厚生労働省 : 第2期アルコール健康障害対策推進基本計画. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000176279.html (閲覧2022年8月)
 
106) 厚生労働省 : 人口動態調査 (平成8年～令和元年). https://www.mhlw.go.jp/toukei/list/81-1a.html (閲覧2022年8月)
 
107) Xie YD et al : Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis : A systematic review and meta-analysis. Hepatol Res 44 : 436-449, 2014
PubMed
108) Lackner C et al : Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol 66 : 610-618, 2017
PubMed
109) Spahr L et al : A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis. Eur J Gastroenterol Hepatol 30 : 967-974, 2018
PubMed
110) Muntaner L et al : High doses of β-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding. Liver Int 30 : 1123-1130, 2010
 
111) Vandenbulcke H et al : Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis : A prospective study. J Hepatol 65 : 543-551, 2016
PubMed
112) Nordback I et al : The recurrence of acute alcohol-associated pancreatitis can be reduced : a randomized controlled trial. Gastroenterology 136 : 848-855, 2009
PubMed
113) Katada C et al : Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology 151 : 860-869.e7, 2016
 
114) Schwarzinger M et al : Contribution of alcohol use disorders to the burden of dementia in France 2008-13 : a nationwide retrospective cohort study. Lancet Public Health 3 : e124-e132, 2018
 
115) Voskoboinik A et al : Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med 382 : 20-28, 2020
PubMed
116) Higuchi S et al : Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome : a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study). J Clin Psychiatry 76 : 181-188, 2015
PubMed
117) National Institute for Health and Clinical Excellence (NICE) : Alcohol use disorders : harmful drinking and alcohol dependence : Evidence Update January 2013 : A summary of selected new evidence relevant to NICE clinical guideline 115 'Alcohol use disorders : diagnosis, assessment and management of harmful drinking and alcohol dependence' (2011), 2013. https://www.ncbi.nlm.nih.gov/books/NBK552038 (閲覧2022年8月)
 
118) 新アルコール・薬物使用障害の診断治療ガイドライン作成委員会 (監) : 新アルコール・薬物使用障害の診断治療ガイドライン, 新興医学出版社, 18-23, 2018
 
119) 尾崎米厚ほか : アルコールの疫学-わが国の飲酒行動の実態とアルコール関連問題による社会的損失のインパクト. 医のあゆみ 274 : 34-39, 2020
Medical*Online
120) 厚生労働省 : 患者調査 (平成29年). https://www.mhlw.go.jp/toukei/list/10-20.html (閲覧2022年8月)
 
121) Miyata H et al : Nalmefene in alcohol-dependent patients with a high drinking risk : Randomized controlled trial. Psychiatry Clin Neurosci 73 : 697-706, 2019
PubMed
122) Simpson RF et al : Alcohol drinking patterns and liver cirrhosis risk : analysis of the prospective UK Million Women Study. Lancet Public Health 4 : e41-e48, 2019
PubMed
123) European Association for the Study of the Liver : EASL Clinical Practice Guidelines : Management of alcohol-related liver disease. J Hepatol 69 : 154-181, 2018
 
124) Kume K et al : Alcohol consumption and the risk for developing pancreatitis : a case-control study in Japan. Pancreas 44 : 53-58, 2015
PubMed
125) Bagnardi V et al : Alcohol consumption and site-specific cancer risk : a comprehensive dose-response meta-analysis. Br J Cancer 112 : 580-593, 2015
 
126) 日本アルコール・アディクション医学会, 日本肝臓学会 : アルコール依存症の診断と治療に関するeラーニング研修. https://gakken-meds.jp/alc/ (閲覧2022年8月)
 

書評

最近チェックした商品履歴

Loading...